The INTERCEPTOR (Interception of Oral Cancer) COST Action addresses the urgent need for better prevention of oral cancer by transforming how oral potentially malignant disorders (OPMDs) are understood, detected, and managed. By combining cutting-edge translational research, AI-driven data science, and harmonized clinical protocols, INTERCEPTOR is paving the way toward personalized prevention strategies and improved patient outcomes across Europe.

This meeting will bring together Working Group 1 (Data Science & Medical Informatics) and Working Group 2 (Disease Care Management) to align efforts in mapping OPMD trajectories, defining temporal markers of cancer progression, and standardizing patient care across Europe.

Visite our dedicated webpage to know all the details of this event.